We came across a bullish\u00a0thesis on The Progressive Corporation on CompoundingLab\u2019s Substack. In this article, we will summarize the bulls\u2019 thesis on PGR. The Progressive Corporation’s share was trading at $205.54 as of February 4th. PGR\u2019s trailing and forward P\/E were 10.45 and 12.56, respectively according to Yahoo Finance.<\/p>\n The Progressive Corporation\u00a0operates\u00a0as an insurance company in the United States.\u00a0PGR appears undervalued, presenting a compelling investment opportunity with potential for significant upside. Based on a dividend discount model, cross-checked with a terminal P\/E multiple, the stock seems\u00a0roughly 25%\u00a0below fair value, implying an expected annual alpha of around 10% if it converges to fair value over the next three years.<\/p>\n The investment case is supported by Progressive\u2019s strong fundamentals, including a long-term EPS growth assumption of 4%, a structurally high ROE of 32%, and a reasonable cost of equity of 6.5%, with a P\/E exit multiple of 14.8x. Progressive is the second-largest U.S. auto insurer by market share, trailing only private competitor State Farm, and boasts the highest 10-year average ROA among listed property and casualty insurers at 5.68%.<\/p>\n Its core competitive advantage lies in data-driven underwriting and pricing at unmatched scale, which continues to support robust profitability even after a recent EPS miss. Sensitivity analysis\u00a0indicates\u00a0that across a wide range of reasonable assumptions, the stock\u00a0remains\u00a0undervalued, with even conservative scenarios suggesting a 6% annual alpha, highlighting the low downside risk. This combination of structural profitability, durable moat, and\u00a0favorable\u00a0valuation underpins a high-confidence investment thesis.<\/p>\n Given the current price,\u00a0initiating\u00a0a position now offers both an attractive entry point and the potential for incremental gains as the market recognizes Progressive\u2019s intrinsic value, with the option to scale the position on weakness. Overall, Progressive\u00a0represents\u00a0a high-quality, underappreciated insurer with steady growth, exceptional returns on capital, and a rare risk\/reward profile among large-cap P&C stocks.<\/p>\n Previously, we covered a\u00a0bullish thesis<\/b>\u00a0on The Progressive Corporation (PGR) by Charly AI in April 2025, which highlighted the company\u2019s strong financial performance, improving profit margins, technological innovation, and undervaluation based on discounted cash flow analysis. PGR\u2019s stock price has depreciated by 21.06% since our coverage.\u00a0CompoundingLab\u00a0shares a similar perspective but emphasizes a valuation-driven approach, highlighting a 25% undervaluation and potential annual alpha of 10% over the next three years.<\/p>\n<\/p><\/div>\n<\/div>\n<\/div>